← Back to Search

Ketone Supplement

Dietary Ketone for Cardiovascular Risk

N/A
Waitlist Available
Led By Kevin Davy, PhD
Research Sponsored by Virginia Polytechnic Institute and State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 45-minute measurement in laboratory
Awards & highlights

Study Summary

This trial is testing whether or not a ketone drink can improve blood vessel health and cognitive health in adults.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~45-minute measurement in laboratory
This trial's timeline: 3 weeks for screening, Varies for treatment, and 45-minute measurement in laboratory for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Arterial Stiffness after Supplementation
Change in Brachial Artery Function after Supplementation
Secondary outcome measures
Change in 24-hour Area Under the Curve for Glucose Levels after Supplementation
Change in Blood Pressure after Supplementation
Change in Executive Cognitive Function after Supplementation
+1 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Dietary KetoneActive Control1 Intervention
Participants will consume three daily ketone drinks (one before each meal) for 2 weeks.
Group II: PlaceboPlacebo Group1 Intervention
Participants will consume three daily placebo drinks (one before each meal) for 2 weeks. .

Find a Location

Who is running the clinical trial?

Virginia Polytechnic Institute and State UniversityLead Sponsor
141 Previous Clinical Trials
27,755 Total Patients Enrolled
3 Trials studying Cardiovascular Risk
65 Patients Enrolled for Cardiovascular Risk
Kevin Davy, PhDPrincipal Investigator - Virginia Polytechnic Institute and State University
Virginia Polytechnic Institute and State University
4 Previous Clinical Trials
107 Total Patients Enrolled
3 Trials studying Cardiovascular Risk
65 Patients Enrolled for Cardiovascular Risk

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment welcome participants who are older than 25 years of age?

"This clinical trial is open to candidates aged 50 or older, yet under 75 years old."

Answered by AI

How many individuals have enrolled in the experiment thus far?

"Affirmative. According to the information accessible on clinicaltrials.gov, this research endeavour is still in search of participants, having first been posted on October 2nd 2020 and last updated on August 15th 2022. 20 people are needed at a single site for enrolment into the trial."

Answered by AI

What results are researchers seeking to obtain through this clinical experiment?

"The primary endpoint of this 45-minute laboratory experiment is to analyse the alteration in brachial artery performance following supplementation. Secondary objectives include assessing changes in glucose tolerance (via an oral glucose drink and multiple blood draws over two hours), modification of blood pressure levels, and 24 hour area under the curve for sugar readings monitored by a Continuous Glucose Monitor worn over three consecutive days. Each participant will be randomly assigned either a ketone or placebo supplement beverage with a biweekly washout period prior to re-administration."

Answered by AI

Are researchers actively enrolling participants in this experiment?

"Affirmative. As per the clinicaltrials.gov listing, this research endeavor is actively seeking participants; it was originally posted on October 2nd 2020 and was recently updated on August 15th 2022. Twenty volunteers need to be enrolled at only one medical site."

Answered by AI

What criteria must participants fulfill to be eligible for this research project?

"This research trial is seeking 20 individuals with a heightened risk for cardiovascular disease, who are between 50 and 75 years of age. The primary requisites necessitate that the patient must be from sedentary to recreationally active, possess a BMI lower than 35 kilograms per meter squared."

Answered by AI
~2 spots leftby Apr 2025